Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Infanrix Hexa TM
Listen to the Pronunciation:
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: haemophilus influenzae type b conjugate (prp-t) vaccine, diphtheria + tetanus + pertussis + hepatitis b + polio trivalent vaccine, hepatitis b vaccine, diphtheria + tetanus + pertussis 3 component + polio trivalent vaccine, diphtheria + tetanus + pertussis 3 component vaccine, polio trivalent inactivated vaccine, diphtheria + tetanus vaccine
Brand name
(ARTG)
: INFANRIX HEXA injection composite pack (pre-filled syringe and vial)Consumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
INFANRIX hexa is indicated for primary immunisation of infants from the age of 6 weeks against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and Haemophilus influenzae type b. INFANRIX hexa is also indicated for use as booster dose if boosting with hepatitis B, poliomyelitis, and Haemophilus influenzae type b, as well as diphtheria, tetanus and pertussis is required. Refer to DOSAGE AND ADMINISTRATION for further information.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intramuscular
- Pellet
Component :
- Injection, suspension
- Intramuscular
- Turbid liquid, white deposit, colourless supernatant
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Shelf lifetime is 4 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 syringe (0.5 mL) and 1 monodose vial pack
- 10 syringes (0.5mL) and 10 monodose vials pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient haemophilus influenzae type b conjugate (prp-t) vaccine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Vaxelis | NCIRS
DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) – frequently asked questions NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety Key points There are two hexavalent combination vaccines – Vaxelis® and Infanrix hexa® – available on the National Immunisation Program (NIP) that protect against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, polio and Haemophilus influenzae type b (Hib)
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Japanese encephalitis | NCIRS
Japanese encephalitis NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety The Japanese encephalitis (JE) situation in Australia has been declared a Communicable Disease Incident of National Significance as of March 2022
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
COVID-19 vaccines: Frequently asked questions (FAQs) | NCIRS
COVID-19 vaccines: Frequently asked questions (FAQs) COVID-19 Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety COVID-19 Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety Key points COVID-19 is a disease caused by the SARS-CoV-2 virus
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Tetanus vaccine | Australian Government Department of Health, Disability and Ageing
Information about tetanus vaccines, who it is recommended for, how and where to get vaccinated. If you're eligible, you can get the tetanus vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Diphtheria vaccine | Australian Government Department of Health, Disability and Ageing
Information about diphtheria vaccines, who it is recommended for, how and where to get vaccinated. If you’re eligible, you can get the diphtheria vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Whooping cough (pertussis) vaccine | Australian Government Department of Health, Disability and Ageing
Information about the whooping cough vaccine, who they are recommended for and possible side effects. If you're eligible, you can get the whooping cough vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Polio (poliomyelitis) vaccine | Australian Government Department of Health, Disability and Ageing
Information about polio vaccines, who it is recommended for, how and where to get vaccinated. If you're eligible, you can get the polio vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Hepatitis B vaccine | Australian Government Department of Health, Disability and Ageing
Information about hepatitis B vaccines, who it is recommended for, how and where to get vaccinated. If you're eligible, you can get the hepatitis B vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Hib (Haemophilus influenzae type b) vaccine | Australian Government Department of Health, Disability and Ageing
Information about Hib vaccines, who it is recommended for, how and where to get vaccinated. Eligible people can get the Hib vaccine for free under the National Immunisation Program.
Read more on Australian Government Department of Health, Disability and Ageing website
Pertussis (whooping cough) | The Australian Immunisation Handbook
Information about pertussis (whooping cough) disease, vaccines and recommendations for vaccination from the Australian Immunisation Handbook
Read more on Australian Government Department of Health, Disability and Ageing website
Top results
Supporting conversations about vaccinations with Aboriginal and Torres Strait Islander people | NCIRS
Supporting conversations about vaccinations with Aboriginal and Torres Strait Islander people NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS fact sheets, FAQs and other resources Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources COVID-19 DTPa-HB-IPV-Hib vaccine (Vaxelis® and Infanrix hexa®) Haemophilus influenzae type b (Hib) Hepatitis B Human papillomavirus Influenza Japanese encephalitis Measles Measles vaccination catch-up guide Meningococcal Mpox (formerly known as monkeypox) Mumps Pertussis Pneumococcal Poliomyelitis Respiratory syncytial virus (RSV) Rotavirus Rubella Varicella-zoster (chickenpox) Zoster (shingles) Injection site reactions Vaccine components Vaccines for Australian adults Vaccinations during pregnancy NCIRS webinar series Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety This page is for immunisation providers (e
Read more on National Centre for Immunisation Research and Surveillance (NCIRS) website
Pertussis Guide for Health Care Professionals - Immunisation Coalition
Pertussis is a highly contagious bacterial infection affecting the respiratory system, that can cause severe illness and death.
Read more on Immunisation Coalition website
